Meiogenix Meiogenix Research Triangle Park, Durham, North Carolina, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Industry Veterans from ...

LivingPhoenix Regenerative Technologies has drawn widespread international attention this November, presenting its ...

TARGETED treatments for prostate cancer were a central theme at the European Society for Medical Oncology (ESMO) Congress ...

Scientists comment on a UK Health Security Agency (UKHSA) announcement that a new mpox strain has been identified in England. Dr Jonas Albarnaz, Institute Fellow, Capripoxvirus Biology, Pirbright ...

Every December, I review the past 12 months and write about the things I learned. When I began writing this column 15 years ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...

Health authorities in the UK have detected a new hybrid strain of Mpox in a patient who recently travelled from Asia. The ...

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

The buried remains of a small child, discovered nearly a century ago in a cave on Israel’s Mount Carmel, are once again at ...

Streeting says ‘terrifying’ virus surge and doctors’ strike could collapse NHS - Hospitalisations for flu in England hit ...

A hybrid form of mpox has been identified in the UK. Health professionals are not surprised that the sexually transmitted ...

Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.